Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of California, Davis
Age
Any age
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Participants must be male and have a pathological diagnosis of prostate cancer.
No treatment (surgery \[RRP\], radiation, or hormones) prior to study entry.
The patient has decided, after consultation with his own doctor, to have no treatment intervention (surgery \[RRP\], radiation, or hormones) for the next six months.
PSA between 2.0 and 10.0 ng/ml.
If PSA is \>10.0, patient must have been on Active Surveillance for 12 months prior to study initiation.
No known allergy to soy or soy products.
The patient is not currently taking more than 2 grams of genistein a day in nutritional or diet enhancing supplements (OTC supplements).
\-
You may not be if
No pathological documentation of prostate cancer.
Allergy to soy or soy products
Prior history of treatment for prostate cancer.
\-
Clareo Health | Effects of GCP on Prostate Cancer.
